About
3.03EUR+0.00 +0.07%
Closed • Updated at 19:00 GMT+00:00Market Cap$277.35M
Volume372.3K
Beta0.66
RSI66.98
Oryzon Genomics Sa — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 29 2026
ORYZON to Participate in Upcoming Events in May and June
Mar 25 2026
ORYZON Strengthens Vafidemstat Patent Portfolio With U.S. Notice of Allowance
Mar 23 2026
ORYZON Announces U.S. Patent Grant Covering Iadademstat Combinations with Venetoclax
Mar 12 2026
ORYZON Expands Patent Protection for Iadademstat with Grant Decision in Mexico Covering Combinations with PD-1/PD-L1 Inhibitors
Feb 27 2026
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
Translate